Jason W. Lilly's most recent trade in Neogen Corp. was a trade of 388 Common Stock done at an average price of $16.7 . Disclosure was reported to the exchange on April 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp. | Jason W. Lilly | Vice President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.67 per share. | 25 Apr 2023 | 388 | 21,506 (0%) | 0% | 16.7 | 6,468 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 41,965 | 232,194 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2022 | 14,157 | 28,714 | - | - | Restricted Stock Units | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 18,405 | 200,229 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 5,282 | 15,731 | - | - | Restricted Stock Units | |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 636 | 171,824 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Sale of securities on an exchange or to another person at price $ 44.91 per share. | 23 Dec 2021 | 636 | 20,838 (0%) | 0% | 44.9 | 28,563 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.35 per share. | 23 Dec 2021 | 636 | 21,474 (0%) | 0% | 31.4 | 19,939 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 24,202 | 172,460 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Oct 2021 | 5,753 | 10,449 | - | - | Restricted Stock Units | |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.23 per share. | 30 Sep 2021 | 15,998 | 35,998 (0%) | 0% | 20.2 | 323,660 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2021 | 15,998 | 148,258 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Sale of securities on an exchange or to another person at price $ 43.72 per share. | 30 Sep 2021 | 15,998 | 20,000 (0%) | 0% | 43.7 | 699,450 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 96.73 per share. | 03 May 2021 | 350 | 10,003 (0%) | 0% | 96.7 | 33,856 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 92.25 per share. | 13 Apr 2021 | 993 | 10,353 (0%) | 0% | 92.2 | 91,604 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 85.23 per share. | 05 Feb 2021 | 2,265 | 11,346 (0%) | 0% | 85.2 | 193,052 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 82.91 per share. | 06 Jan 2021 | 11,021 | 13,611 (0%) | 0% | 82.9 | 913,716 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 6,600 | 68,400 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 63.90 per share. | 06 Jan 2021 | 6,600 | 24,632 (0%) | 0% | 63.9 | 421,740 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.70 per share. | 06 Jan 2021 | 6,000 | 18,032 (0%) | 0% | 62.7 | 376,200 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 6,000 | 75,000 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,523 | 86,478 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 16 Nov 2020 | 10,523 | 20,932 (0%) | 0% | 40.5 | 425,787 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 73.06 per share. | 16 Nov 2020 | 8,900 | 12,032 (0%) | 0% | 73.1 | 650,253 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Sale of securities on an exchange or to another person at price $ 73.51 per share. | 16 Nov 2020 | 5,478 | 12,032 (0%) | 0% | 73.5 | 402,661 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 16 Nov 2020 | 5,478 | 17,510 (0%) | 0% | 40.5 | 221,654 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 5,478 | 81,000 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Oct 2020 | 6,666 | 97,001 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Sale of securities on an exchange or to another person at price $ 70.62 per share. | 21 Oct 2020 | 6,666 | 10,409 (0%) | 0% | 70.6 | 470,770 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.34 per share. | 21 Oct 2020 | 6,666 | 17,075 (0%) | 0% | 35.3 | 235,576 | Common Stock |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 13,728 | 117,395 | - | - | Common Stock (Right to Buy) | |
| Neogen Corp. | Jason W. Lilly | Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 2,930 | 2,930 | - | - | Restricted Stock Units |